Actively Recruiting
Fecal Microbiota Transplantation by Colonoscopy to Treat Recurrent Clostridium Difficile Infection
Led by Krunal Patel · Updated on 2026-02-20
500
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating fecal microbiota transplantation FMT delivered by colonoscopy as a treatment for patients with recurrent Clostridium difficile infection C. diff. This study aims to record the success rate of FMT using a standardized protocol, compare its cost to conventional antibiotic treatments, and monitor hospitalizations related to recurrent infections. The trial focuses on patients who have experienced multiple C. diff recurrences and failed standard antibiotic therapies. Participants receive a stool transplant from a healthy donor, usually a family member or close friend, directly into their colon via colonoscopy. This procedure is intended to replenish beneficial bacteria in the colon to help prevent further C. diff infection recurrences. The study follows patients over a 12-month period to assess infection resolution and other outcomes. During the study, participants will undergo assessments to monitor the resolution of C. diff infection, with data collected on infection recurrence and hospitalizations. The primary outcome measure is the resolution of C. diff infection within 12 months. The study also compares costs associated with FMT versus traditional antibiotic treatment. Participants health and safety will be monitored throughout the study period, which extends up to several years.
CONDITIONS
Brief Title
Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
Research Team
A
Anne Foley
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here